InMed Pharmaceuticals INM
NASDAQ INM
$1.33 -0.02 (-1.48%)
At close: Oct 2, 2026 · 4:00 PM EDT

InMed Pharmaceuticals (INM) Return on Equity [ROE] (2022 - 2026)

Updated

InMed Pharmaceuticals' Return on Equity [ROE] was -315.33% in fiscal Q4 2026 (quarter ended Jun 30, 2026), down 235.53 percentage points from -79.80% a year earlier and down 212.05 percentage points from the prior quarter.

Analysis

InMed Pharmaceuticals (INM) Return on Equity [ROE] (2022 - 2026) Analysis & Trends

For FY2026 (ended Jun 30, 2026), Return on Equity [ROE] at InMed Pharmaceuticals came in at -173.14%, down 101.04 percentage points from FY2025.

  • Return on Equity [ROE] shows a four-year change of +52.93 percentage points (FY2022 to FY2026).
  • In earlier fiscal years, Return on Equity [ROE] was -72.10% in FY2025 (-0.02 pp), -72.08% in FY2024 (+3.00 pp), -75.09% in FY2023 (+150.98 pp) and -226.07% in FY2022.
  • The fiscal Q4 2026 figure marks the lowest quarterly Return on Equity [ROE] since fiscal Q2 2024.
  • Compared with a year earlier, Return on Equity [ROE] was higher in five of the last eight quarters, with an average year-over-year change of +65.26 percentage points.
  • The best year-over-year quarter for Return on Equity [ROE] over five years was fiscal Q1 2025 (a gain of 477.48 percentage points); the worst was fiscal Q1 2024 (a drop of 364.29 percentage points).
  • Per Business Quant data, INM's Return on Equity [ROE] in the three fiscal quarters before Q4 2026 was -103.28% (Q3 2026), -72.38% (Q2 2026) and -65.62% (Q1 2026).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROE (Qtr)
1 Linde 221.03 Bn 204.14 Bn 4.43 Bn 18.28%
2 Corning 141.47 Bn 134.60 Bn 1.63 Bn 16.28%
3 Sherwin Williams 77.59 Bn 76.63 Bn 3.34 Bn 64.89%
4 Air Products & Chemicals 61.84 Bn 59.74 Bn 1.04 Bn 0.02%
5 LyondellBasell Industries 37.84 Bn 27.46 Bn 2.04 Bn -3.28%
6 Nutrien 33.77 Bn 30.64 Bn 3.25 Bn 9.43%
7 Qnity Electronics 27.51 Bn 24.93 Bn 666.00 Mn 8.40%
8 Ati 26.21 Bn 24.36 Bn 309.80 Mn 25.17%
9 Ppg Industries 23.37 Bn 16.17 Bn 1.81 Bn 18.77%
10 InMed Pharmaceuticals 5.54 Mn 3.34 Mn - -315.33%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -315.33%
Mar 31, 2026 -103.28%
Dec 31, 2025 -72.38%
Sep 30, 2025 -65.62%
Jun 30, 2025 -79.80%
Mar 31, 2025 -125.79%
Dec 31, 2024 -108.47%
Sep 30, 2024 -77.37%
Jun 30, 2024 -75.51%
Mar 31, 2024 -50.88%
Dec 31, 2023 -397.48%
Sep 30, 2023 -554.85%
Jun 30, 2023 -64.89%
Mar 31, 2023 -115.82%
Dec 31, 2022 -133.80%
Sep 30, 2022 -190.56%
Jun 30, 2022 -186.32%
API Access

InMed Pharmaceuticals Return on Equity [ROE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=INM&period=max&api_key=YOUR_API_KEY